Yes I would say that. If the data was obtained via a powered randomised controlled trial.
BSI also said that some 3 years ago.
No statistical conclusions are possible with this, or any other pilot proof of concept study.
Who then is "they"? "They" who report such results. Why would "they" draw such conclusions? What have "they" got to gain by making such declarations?
Perhaps these are better questions for investors to ask.
It's very simple, like it or not. Until "they" is the independent clinical advisors and BSI there is and will be no CE approval.
Ann: CE Marking Update, page-52
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.7¢ | $69.42K | 8.685M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 67 | 28673846 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 7597003 | 11 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |
